(19)
(11) EP 4 739 697 A1

(12)

(43) Date of publication:
13.05.2026 Bulletin 2026/20

(21) Application number: 24737995.1

(22) Date of filing: 05.07.2024
(51) International Patent Classification (IPC): 
C07H 7/04(2006.01)
A61P 3/10(2006.01)
C07H 15/04(2006.01)
A61K 31/7034(2006.01)
(52) Cooperative Patent Classification (CPC):
C07H 7/04; C07H 15/04; A61P 3/10
(86) International application number:
PCT/EP2024/069109
(87) International publication number:
WO 2025/008539 (09.01.2025 Gazette 2025/02)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 06.07.2023 EP 23460026

(71) Applicant: Zaklady Farmaceutyczne Polpharma S.A.
83-200 Starogard Gdanski (PL)

(72) Inventors:
  • KAMI SKA, Ewelina
    80-288 Gda sk (PL)
  • PUNDA, Pawe
    83-200 Okole (PL)

(74) Representative: Kondrat, Mariusz 
Kondrat & Partners Al. Niepodleglosci 223/1
02-087 Warszawa
02-087 Warszawa (PL)

   


(54) PROCESS FOR THE PREPARATION OF DAPAGLIFLOZIN